BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol.
David PasquierEmilie BogartFrançois BonodeauThomas LacornerieEric LartigauIgor LatorzeffPublished in: BMC cancer (2018)
NCT02478112 , date of registration: 15/06/2015.